Clinical Trial 50719

Berlin, NJ 08009


A Phase 1, randomized, parallel group, single-dose clinical pharmacology study to investigate the safety, tolerability, and pharmacokinetics of two different concentrations of sotrovimab administered in male or female healthy participants aged 18 to 65 years.

Qualified Participants Must:

• Be 18-65 years old
• Have completed the COVID-19 vaccine series (Booster NOT required)
• Be in general good health
• Be negative for COVID-19
• Have a BMI of 18-30 kg/m2

Qualified Participants May Receive:

  • Up to $6,535 for time and travel
  • No insurance needed and transportation available

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.